close
ACE2, CD147, and COVID-19: A Tale of Two Receptors
shop evolutamente

ACE2, CD147, and COVID-19: A Tale of Two Receptors

By Doris Loh

The following slide presentation was used for the interview by Jay Campbell on July 1, 2020.  Contents may be shared and reprinted providing proper credit for the original podcast and this article is given.

The July 1 video can be accessed via this URL  https://www.youtube.com/watch?v=vAiVjRWubSc&feature=youtu.be

 

 

 

 

 

 

 

 

 

 

 

(Visited 1.966 times, 2 visits today)
Doris Loh

Doris Loh

Doris Loh is an independent researcher and writer specializing in the investigation of familiar and innovative health topics using unique perspectives in traditional and quantum biology. Her training as a classical pianist allows her the freedom to explore concepts and theories with a curiosity that often results in distinctive conclusions. Recent works by Doris are focused on how health and disease are greatly affected by electromagnetic radiation that surround us everywhere we go. Her works on EMF offer insight and solutions to the challenges humans and other living organisms face during this era of change. Major works by Doris include an in-depth series on deuterium, as well as a startling series on the birefringent quantum properties of the major REDOX balancer, Vitamin C (ascorbic acid). The ongoing series on COVID-19 is recognized around the world for the in-depth coverage of the disease and discussion on holistic alternatives for prevention and treatment.

VITAMINA D INTEGRATA SELVAGGIAMENTE: E’ IMMUNOSOPPRESSIVA SEMPRE!

INCHIESTA: L’INFLUENZA SPAGNOLA (1918-1919)